Back
Blueprint Medicines Stock Predictions

BOXABL Announces New $20,000 House
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular here. This is a message from Boxabl
Sell
45
BPMC
Blueprint Medicines
Last Price:
$101.53
Seasonality Move:
3.52%
7 Day Trial
ALL ACCESS PASS
$
7

Elon Musk Dreams, Mode Mobile Delivers
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Blueprint Medicines Stock Forecast
-
Over the next 52 weeks, Blueprint Medicines has on average historically risen by 37.9% based on the past 9 years of stock performance.
-
Blueprint Medicines has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
-
Is Blueprint Medicines Stock Undervalued?The current Blueprint Medicines [BPMC] share price is $104.00. The Score for BPMC is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Blueprint Medicines Stock Go Up Next Year?
-
Over the next 52 weeks, Blueprint Medicines has on average historically risen by 37.9% based on the past 9 years of stock performance.
Blueprint Medicines Stock Rating
Sell
45
Blueprint Medicines (BPMC)
is a Sell
Is Blueprint Medicines overpriced?
-
Blueprint Medicines has risen higher in 5 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
Blueprint Medicines Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blueprintmedicines.com
52-Week Data
52-Week High:
121.90
52-Week Low:
72.24
Prediction Charts
Market Cap:
6.6B
Price in USD:
104.00
Volume:
1.8M
Beta:
0.91
Technical Analysis
SMA50:
99.51
SMA100:
95.02
SMA200:
98.69
52-Wk Change:
35.88%
Stock Predictions
-
Is Blueprint Medicines stock public?Yes, Blueprint Medicines is a publicly traded company.
-
What is the Blueprint Medicines stock quote today?The Blueprint Medicines stock price is 104.00 USD today.
-
How to buy Blueprint Medicines stock online?You can buy Blueprint Medicines shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Jan-22 | 111.54 | 111.08 | 113.57 | 110.80 |
Jan-23 | 111.26 | 115.63 | 116.12 | 111.26 |
Jan-24 | 114.75 | 114.91 | 117.48 | 114.64 |
Jan-27 | 113.90 | 113.88 | 118.25 | 113.31 |
Jan-28 | 114.41 | 114.47 | 115.35 | 113.40 |
Jan-29 | 113.87 | 114.32 | 117.09 | 113.68 |
Jan-30 | 115.00 | 114.05 | 116.00 | 112.73 |
Jan-31 | 114.49 | 112.53 | 116.23 | 112.18 |
Feb-3 | 109.20 | 111.50 | 112.70 | 109.06 |
Feb-4 | 110.61 | 113.40 | 114.14 | 110.61 |
Feb-5 | 113.55 | 110.37 | 115.77 | 110.17 |
Feb-6 | 110.37 | 109.62 | 112.00 | 108.84 |
Feb-7 | 109.43 | 104.98 | 110.55 | 103.98 |
Feb-10 | 105.15 | 104.00 | 105.15 | 100.76 |
Blueprint Medicines Earnings
Blueprint Medicines Earnings Report: Per Share Blueprint Medicines Earnings Q1 Q2 Q3 and Q4 last year and next year.
Blueprint Medicines Forecast Revenue Growth
Blueprint Medicines Stock Analysis: Historical quarterly revenues per share for Blueprint Medicines and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.64 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.39 per share, and an increase next year of $2.97 per share.
* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.